Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-92.86	-71.93	1006.97
Graham Fair Price	inf	0.00	18.14
PEG	inf	0.00	-0.36
Price/Book	inf	0.00	0.54
Price/Cash Flow	0.00	0.00	0.00
Prices/Earnings	inf	0.00	27.35
Price/Sales	inf	0.00	5.54
Price/FCF	0.00	0.00	0.00
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	0.00	1.00	1.00
Operating Margin	219.33	0.25	0.08
ROA	209.89	< 0.005	< 0.005
ROE	< 0.005	0.02	207.46
ROIC	< 0.005	0.01	2653.18
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	-0.99	75.47	-98.69
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.69	1.88	173.45
EPS QOQ	-0.76	-1.00	-32.20
FCF QOQ	0.00	0.00	0.00
Revenue QOQ	0.08	-0.10	19.36
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	260.03	-88.74	-65.87
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.90	0.10	-89.21
Quick Ratio	477.40	0.00	inf
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	54.34	0.00	inf
Cash	105.08	0.00	inf
Capex	n.A.	0.00	n.A.
Free Cash Flow	n.A.	0.00	n.A.
Revenue	5.31	0.00	inf
Naive Interpretation	member

05 - Per Share Metrics · Not Interpreted

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	477.40	0.00	inf
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	936.96	-71.93	-92.32
Naive Interpretation	Member

06 - Financial Health · Bad

Rating